# Vanta Bioscience Ltd (VANTABIO)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹18
Day Change: +0%
52W High: ₹31.33
52W Low: ₹14.71
Market Cap: ₹13 Cr

## Valuation
P/E: 0
P/B: 0.66
EPS: ₹-6.84
Book Value: ₹27.09
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Vanta Bioscience Ltd is a Diagnostics & Research company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Vanta Bioscience Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Announcement: Closure of Trading Window
- BSE Filing: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-17T00:09:40.733Z
Price History Updated: 2026-05-25T05:37:36.500Z
Latest Price History Date: 2026-05-15
Technicals Updated: 2026-05-25T05:37:36.500Z
Quant Updated: 2026-05-25T05:37:36.500Z
Sentiment Updated: 2026-05-25T05:37:36.500Z
Financials Status: current
Financials Updated: 2026-05-18T16:30:02.025Z
Financials Last Attempt: 2026-05-18T16:30:02.025Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2020)
Revenue: ₹12.08 Cr
Operating Profit: ₹3.27 Cr (OPM 27.07%)
Net Profit: ₹0.7 Cr
Tax: ₹1.1 Cr

## Annual P&L History
Mar 2020: Rev ₹12.08Cr | PAT ₹0.7Cr | OPM 27.07%
Mar 2021: Rev ₹13.75Cr | PAT ₹1.01Cr | OPM 31.78%
Mar 2022: Rev ₹9.82Cr | PAT ₹0.45Cr | OPM 40.22%

## Balance Sheet (Mar 2020)
Total Assets: ₹39.01 Cr
Total Liabilities: ₹39.01 Cr
Borrowings: ₹13.25 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/vantabio
Disclaimer: For research and education only. Not investment advice.